Synergy Spine Solutions Completes Patient Enrollment in Clinical Trial
Synergy Spine Solutions Ltd, an innovative orthopedic medical device firm specializing in artificial cervical disc replacement, has achieved a significant milestone: the completion of patient enrollment in its U.S. 2-Level IDE clinical trial. This groundbreaking trial is designed to evaluate how safe and effective the Synergy Disc® artificial cervical disc is for treating degenerative disc disease.
Understanding the Importance of the 2-Level IDE Trial
This clinical trial operates under a U.S. Investigational Device Exemption (IDE) and compares the Synergy Disc to traditional anterior cervical discectomy and fusion (ACDF) methods. It specifically targets patients experiencing symptoms at two connected levels from C3 to C7. The study is multi-center, prospective, and historically controlled, involving 200 patients participating across 24 clinical sites in the U.S.
Insights from Leading Surgeons
Dr. Pierce Nunley, an orthopedic spine surgeon at the Spine Institute in Louisiana and participant in numerous cervical total disc replacement trials, shares his enthusiasm for the project: "I'm impressed by how easy and safe the Synergy Disc is to use in surgery. This disc is unique because it’s the only one with a lordotic core designed to maintain or restore spinal alignment." He notes that this design could potentially make total disc replacement (TDR) accessible to more patients who need multi-level disc surgeries.
Dr. Armen Khachatryan from West Jordan, Utah, also offers insights into the Synergy Disc’s exceptional design. He states, "The Synergy Disc marks a significant step forward in spinal surgery, featuring innovative elements like lordotic core options and titanium alloy endplates. Its straightforward implantation technique makes it adaptable for both single-level and two-level procedures." He is eagerly looking forward to the anticipated FDA approval, which could broaden the applications for this device.
The Impact of Completing Enrollment
Finishing patient enrollment is a vital step for Synergy Spine Solutions in its pursuit of U.S. FDA regulatory approvals. This progress will likely expedite the Synergy Disc’s journey to market and strengthen its competitive position within the industry.
A Note from the CEO
Josh Butters, CEO of Synergy Spine Solutions, expresses pride in this significant accomplishment: "This is an incredibly exciting moment for the entire Synergy team and our shareholders. We completed enrollment ahead of schedule in half the time it took for our 1-Level IDE trial. We've received outstanding feedback so far, and I’m looking forward to the results from both trials. The unique features of the Synergy Disc, along with the forthcoming clinical outcomes, should reveal the benefits of our technology." Butters also acknowledges the important collaboration with clinical sites and investigators, appreciating their hard work in bringing this project to life.
About Synergy Spine Solutions
Synergy Spine Solutions aims to discover and commercialize revolutionary spinal technologies that improve the quality of life for patients and elevate standards of care. The company’s flagship product, the Synergy Disc, is designed to restore both motion and alignment to the spine, representing a transformative approach in spinal surgery.
Frequently Asked Questions
What is the aim of the Synergy Spine Solutions clinical trial?
The trial aims to evaluate the safety and effectiveness of the Synergy Disc® artificial cervical disc for treating degenerative disc disease.
Where is the clinical trial conducted?
The trial is being conducted at 24 clinical sites across the U.S.
Who are the key surgeons involved in the trial?
Prominent orthopedic spine surgeons like Dr. Pierce Nunley and Dr. Armen Khachatryan are involved as principal investigators in the trial.
What makes the Synergy Disc unique?
The Synergy Disc features a lordotic core that helps maintain or restore spinal alignment, making it suitable for multi-level disc surgeries.
What are the next steps for Synergy Spine Solutions?
The company is focused on obtaining FDA approval for the Synergy Disc while analyzing the results of the ongoing clinical trials.
